Listen Now
Topics Covered
- Review of Chronic Lymphocytic Leukemia (CLL)
- Significant Role of Testing in Informing Your Treatment Choices
- First Line Treatment Options
- Treatment for Relapsed & Refractory CLL
- Re-Testing Importance in Determining Treatment for 2nd & 3rd Line Treatments
- Current Perspectives on New & Emerging Treatment of CLL
- Updates on Clinical Trials & Their Significance for CLL
- Key Questions to Ask & Re-Ask Your Health Care Team
- Practical and Psychosocial Support to Cope with CLL
- Questions for Our Panel of Experts
Our Panel of Experts

Jennifer R. Brown, MD, PhD
Professor of Medicine, Harvard Medical School, Director, CLL Center, Dana-Farber Cancer Institute

Mazyar Shadman, MD, MPH
Physician, Seattle Cancer Care Alliance, Assistant Professor, Division of Medical Oncology, University of Washington School of Medicine, Assistant Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center

Patricia Koffman
Co-Founder and Executive Director, CLL Society, Inc.

Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on April 30, 2020.